The Journal of Internal Korean Medicine (대한한방내과학회지)

The Society of Internal Korean Medicine (대한한방내과학회)
권호 표지
DOI QR코드

DOI QR Code

Reduction of Allergic Rhinitis by Controlling the Th2 Differentiation of Douchi Hataedock

두시하태독법의 Th2 분화 조절을 통한 알레르기 비염 완화 효과

  • Choi, Jun-yong (Dept. of Internal Medicine, Korean Medicine Hospital of Pusan National University) ;
  • Ahn, Sang-hyun (Dept. of Anatomy, College of Korean Medicine, Se-Myung University) ;
  • Kim, Ki-bong (Dept. of Pediatrics, Korean Medicine Hospital of Pusan National University)
  • 최준용 (부산대학교한방병원 한방내과) ;
  • 안상현 (세명대학교 한의과대학 해부학교실) ;
  • 김기봉 (부산대학교한방병원 한방소아과)
  • Received : 2017.09.12
  • Accepted : 2017.09.25
  • Published : 2017.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: This study investigated the effects of Douchi Hataedock on Th2-skewed conditions to control allergic rhinitis. Methods: NC/Nga mice were divided into three groups: 10 mice were assigned to the control group (CTRL; no treatment), 10 mice to allergic rhinitis-induced (ARE) without treatment group, and 10 mice to the allergic rhinitis-induced (FGT) after Douchi Hataedock treatment group. The 3-week-old mice of the FGT group were given one 10 mg/kg dose of Douchi Hataedock extract and resensitized to allergic antigens at weeks four, five, and six. Allergic rhinitis was induced primarily in mice nasal cavities for five days after one week of final sensitization. The second induction used the same method one week after the first induction was completed. After one week, the nasal mucosal tissues of each group were observed. Immunohistochemical staining for IL-4, STAT6, CD40, $Fc{\varepsilon}RI$, substance P, MMP-9, $NF-{\kappa}B$ p65, p-IkB, and iNOS in the nasal mucosa was also performed. Results: The FGT group had less respiratory epithelial damage and less mucin secretion in goblet cells than the ARE group and showed a 62% decrease in IL-4, 85% decrease in STAT6, 71% decrease in CD40, 69% decrease in $Fc{\varepsilon}RI$, 43% decrease in substance P, 49% decrease in MMP-9, 43% decrease in NF-kB p65, 38% decrease in p-IkB, and 73% decrease in iNOS compared to the ARE group. Conclusions: Douchi Hataedock lessens inflammation in epithelial and goblet cells and reduces inflammatory mediator secretion in a mouse allergic rhinitis model.

Keywords

References

  1. Ko MJ, Lee YJ, Baek JH. A Clinical Study on the Effect of Traditional Korean Treatment on Pediatric Rhinitis. J Pediatr Korean Med 2011;25(3):12-26. https://doi.org/10.7778/jpkm.2011.25.3.012
  2. David PS. Allergic rhinits: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy ClinImmunol 2001;108:2-8.
  3. Kim JE, Baek JH. Research of Pattern Identification and Outcome Measurement in Allergic Rhinitis. J Pediatr Korean Med 2016;30(1):32-9. https://doi.org/10.7778/jpkm.2016.30.1.032
  4. Allergic Rhinitis and its Impact on Asthma (ARIA) in collaboration with the World Health Organization, Global Allergy and Asthma European Network (GA2LEN), AllerGen NCE Inc. : ARIA Guidelines [Internet]. The 2008 revision of the ARIA Report. Available from: http://www.whiar.org/Documents&Resources.php.
  5. Koo EJ, Han JK, Kim YH. Review of Clinical Studies on Korean Medicine and Complementary and Alternative Medicine Treatment for Allergic Rhinitis in the Korean Literature. J Pediatr Korean Med 2015;29(4):77-89. https://doi.org/10.7778/jpkm.2015.29.4.077
  6. Brozek JL, Bousquet J, Agache I, Agarwal A, Bachert C, Bosnic-Anticevich S, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision. J Allergy ClinImmunol 2017 pii: S0091-6749(17)30919-3. DOI: http://dx.doi.org/10.1016/j.jaci.2017.03.050
  7. Kim JS, Kang HS, Jang HJ, Kim JH, Lim DH, Son BK. Clinical features of allergic rhinitis in Korean children. Allergy Asthma Respir Dis 2015;3(2):116-23. https://doi.org/10.4168/aard.2015.3.2.116
  8. Woo HS, Kim CH. The Review of Oriental Medical Therapy on Allergic Rhinitis. J Korean Oriental Med 2006;27(1):155-64.
  9. Kim JH, Shin SH, Kim MB, Ko WS, Yoon HJ. Systemic review : The study on alternative medicine for allergic rhinitis in Entrez Pubmed. J Korean Med Ophthalmol Otolaryngol Dermatol 2007;20(1):239-49.
  10. Leung DY. Atopic dermatitis: new insights and opportunities for therapeutic intervention. J Allergy Clin Immunol 2000;105(5):860-76. https://doi.org/10.1067/mai.2000.106484
  11. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136(7):2348-57.
  12. Saini V, Arora S, Yadav A, Bhattacharjee J. Cytokines in recurrent pregnancy loss. Clinica Chimica Acta 2011;412(9-10):702-8. https://doi.org/10.1016/j.cca.2011.01.002
  13. Son JH, Jeong JH, Yoo DY. Effects of Pal-Mul-Tang on Cytokines Production from Immune cells during the late stage of Pregnancy in BALB/c mice. J Oriental Gynecology 2000;13(1):342-75.
  14. Jung AR, Ahn SH, Cheon JH, Park IS, Kim JT, Jeong SI, et al. Douchi (Glycine Semen Preparatum) alleviates atopic dermatitis-like skin lesions in NC/Nga mice by regulation of PKC and Th2 cytokines. BMC Complement Altern Med 2016;16:416. https://doi.org/10.1186/s12906-016-1394-4
  15. Aum SH, Ahn SH, Park SY, Cheon JH, Kim KB. The Anti-inflammatory Effects of Hataedock Taken Douchi Extracts on Atopic Dermatitis-like Skin Lesion of NC/Nga Mouse. J Pediatr Korean Med 2016;30(2):1-9. https://doi.org/10.7778/JPKM.2016.30.2.001
  16. Ahn SH, Kim JK, Cheon JH, Kim KB. The Effect of DouchiHataedock Treatment for Dermatophagoides Farinae-Induced Atopic Dermatitis-like Skin Lesions by Controlling IL-4 Activity. J Pediatr Korean Med 2017;31(1):43-51. https://doi.org/10.7778/jpkm.2017.31.1.043
  17. Kim JW. Atopic dermatitis form allergy and immunological perspective. Kor J dermatology 2003;41(6):687-9.
  18. Park YM. Advances In the Pathophysiology of Atopic Dermatitis. Allergy Asthma & Respir Dis 2006;16(3):189-96.
  19. Romagnani S. Regulation of the development of type 2 T-helper cells in allergy. Curr Opin Immunol 1994;6(6):838-46. https://doi.org/10.1016/0952-7915(94)90002-7
  20. Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev 2003;8(3):223-46.
  21. Romagnani S. T-cell subsets (Th1 versus Th2). Ann Allergy Asthma Immunol 2000;85(1):9-21. https://doi.org/10.1016/S1081-1206(10)62426-X
  22. Akdis M, Akdis CA. IgE class switching and cellular memory. Nat Immunol 2012;13(4):312-4. https://doi.org/10.1038/ni.2266
  23. Leek JP, Hamlin PJ, Bell SM, Lench NJ. Assignment of the STAT6 gene (STAT6) to human chromosome band 12q13 by in situ hybridization. Cytogenetics and Cell Genetics 1997;79(3-4):208-9. https://doi.org/10.1159/000134723
  24. Hou J, Schindler U, Henzel WJ, Ho TC, Brasseur M, McKnight SL. An interleukin-4-induced transcription factor: IL-4 Stat. Science 1994;265(5179):1701-6. https://doi.org/10.1126/science.8085155
  25. Amin K. The role of mast cells in allergic inflammation. Respir Med 2012;106(1):9-14. https://doi.org/10.1016/j.rmed.2011.09.007
  26. Metcalfe DD, Baram D, Mekori YA. Mast cells. Physiol Rev 1997;77(4):1033-79. https://doi.org/10.1152/physrev.1997.77.4.1033
  27. Stone KD, Prussin C, Metcalfe DD. IgE, Mast Cells, Basophils, and Eosinophils. J Allergy Clin Immunol 2010;125(2 Suppl 2):S73-S80. https://doi.org/10.1016/j.jaci.2009.11.017
  28. Park SW, Yan YP, Satriotomo I, Vemuganti R, Dempsey RJ. Substance P is a promoter of adult neural progenitor cell proliferation under normal and ischemic conditions. J Neurosurg 2007;107(3):593-9. https://doi.org/10.3171/JNS-07/09/0593
  29. Donkin JJ, Turner RJ, Hassan I, Vink R. Substance P in traumatic brain injury. Prog Brain Res 2007;161:97-109.
  30. Ebner K, Singewald N. The role of substance P in stress and anxiety responses. Amino Acids 2006;31(3):251-72. https://doi.org/10.1007/s00726-006-0335-9
  31. Yamaoka J, Kawana S. Rapid changes in substance P signaling and neutral endopeptidase induced by skin-scratching stimulation in mice. J Dermatol Sci 2007;48(2):123-32. https://doi.org/10.1016/j.jdermsci.2007.06.007
  32. Woessner JF Jr. MMPs and TIMPs-an historical perspective. Mol Biotechnol 2002;22(1):33-49. https://doi.org/10.1385/MB:22:1:033
  33. Burrage PS, Mix KS, Brinckerhoff CE. Matrix metalloproteinases ; role in arthritis. Front Biosci 2006;11:529-43. https://doi.org/10.2741/1817
  34. Onodera S, Kaneda K, Mizue Y, Koyama Y, Fujinaga M, Nishihira J. Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblast of rheumatoid arthritis. J Biol Chem 2000;275(1):444-50. https://doi.org/10.1074/jbc.275.1.444
  35. Baeuerle PA, Baltimore D. $NF-{\kappa}B$ - Ten years after. Cell 1996;87:13-20. https://doi.org/10.1016/S0092-8674(00)81318-5

Cited by

  1. 두시 하태독법이 시행된 비만 생쥐에서 Th2 분화조절을 통한 알러지성 비염 유발 감소 효과 vol.32, pp.2, 2018, https://doi.org/10.7778/jpkm.2018.32.2.001
  2. 알레르기성 비염에서 황련-감초 하태독법의 IL-4활성 조절을 통한 항염증효과 vol.33, pp.2, 2019, https://doi.org/10.15188/kjopp.2019.04.33.2.116